Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator ...
The FDA on Thursday promised to start posting its drug rejection letters shortly after they're issued to the pharmaceutical companies sponsoring the products. The agency also published 89 of the ...